Clinical trial
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac…
NCT00115349 · Carelon Research, Other · Terminated
Key facts
| NCT number | NCT00115349 |
|---|---|
| Title | Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases |
| Official title | Thalassemia Clinical Research Network - Cardiac L1/DFO Trial |
| Lead sponsor | Carelon Research, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Beta-Thalassemia |
| Intervention type | Drug |
| Interventions | Deferoxamine, Deferiprone (L1) |
| Enrollment | 20 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Jun 22, 2005 |
| Last update posted | Mar 1, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: